Open AccessEmerging Role of Myeloperoxidase in the Prognosis of Nephrotic Syndrome Patients Before and After Steroid Therapy
Author(s) -
S Souparnika,
Benedicta D’Souza,
Vivian D’Souza,
Sampath Kumar,
Poornima Manjrekar,
Manohar Bairy,
R. Parthasarathy,
Srinivas Kosuru
Publication year - 2015
Publication title -
journal of clinical and diagnostic research
Language(s) - English
Resource type - Journals
eISSN - 2249-782X
pISSN - 0973-709X
DOI - 10.7860/jcdr/2015/12532.6222
Subject(s) - nephrotic syndrome , creatinine , myeloperoxidase , medicine , renal function , gastroenterology , blood urea nitrogen , globulin , albumin , hypoalbuminemia , endocrinology , inflammation
Myeloperoxidase (MPO) is a myelocyte derived iron containing enzyme particularly involved in host defense by destroying foreign micro organisms invading the body. Numerous evidences suggest that MPO is involved in the pathogenesis of many inflammatory diseases, especially atherosclerosis.